ID
14531
Beschrijving
Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00148070
Link
https://clinicaltrials.gov/show/NCT00148070
Trefwoorden
Versies (1)
- 19-04-16 19-04-16 -
Geüploaded op
19 april 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Metastatic Breast Cancer NCT00148070
Eligibility Metastatic Breast Cancer NCT00148070
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Age
Datatype
boolean
Alias
- UMLS CUI [1]
- C0001779
Beschrijving
Allergy to erythromycin
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0014806
Beschrijving
Docetaxel and paclitaxel
Datatype
boolean
Alias
- UMLS CUI [1]
- C0246415
- UMLS CUI [2]
- C0144576
Beschrijving
Peripheral neuropathy grade
Datatype
boolean
Alias
- UMLS CUI [1]
- C3869673
Beschrijving
Confounding factors
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009673
Beschrijving
Gynaecological status
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3,1]
- C3831118
- UMLS CUI [3,2]
- C0032976
Beschrijving
Cyp3a inhibitors
Datatype
boolean
Alias
- UMLS CUI [1]
- C3850056
Similar models
Eligibility Metastatic Breast Cancer NCT00148070
- StudyEvent: Eligibility
C0153690 (UMLS CUI [2])
C0747641 (UMLS CUI [3])
C0019046 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0232804 (UMLS CUI [2])
C0014806 (UMLS CUI [1,2])
C0144576 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0032976 (UMLS CUI [3,2])